Corcept Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT)…. Read MoreJoin Investigation
